http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2025, Vol. 34 ›› Issue (10): 954-966.DOI: 10.5246/jcps.2025.10.071

• 【研究论文】 • 上一篇    下一篇

基于世界卫生组织/国际健康行动机构标准调查法的湖北省血糖仪及血糖试纸价格组成分析

郑佳宁1,2, 柳羽姝1,2, 王茜1,2, 李虹烨3, 刘晨曦1,2,*()   

  1. 1. 华中科技大学医药卫生管理学院, 湖北 武汉 430030
    2. 华中科技大学文科双一流建设重大学科平台(医院高质量发展研究中心), 湖北 武汉 430030
    3. 加利福尼亚大学洛杉矶分校, 美国 洛杉矶 90095
  • 收稿日期:2025-04-20 修回日期:2025-05-11 接受日期:2025-06-08 出版日期:2025-11-03 发布日期:2025-11-03
  • 通讯作者: 刘晨曦

Price composition analysis of blood glucose meters and blood glucose test strips in Hubei Province based on the World Health Organization/Health Action International standard survey method

Jianing Zheng1,2, Yushu Liu1,2, Xi Wang1,2, Hongye Li3, Chenxi Liu1,2,*()   

  1. 1 School of Medicine and Health Management, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China
    2 Major Disciplinary Platform under Double First-Class Initiative for Liberal Arts at Huazhong University of Science and Technology (Research Center For High-Quality Development of Hospitals), Wuhan 430030, Hubei, China
    3 University of California, Los Angeles 90095, USA
  • Received:2025-04-20 Revised:2025-05-11 Accepted:2025-06-08 Online:2025-11-03 Published:2025-11-03
  • Contact: Chenxi Liu
  • Supported by:
    Hubei Provincial Medical Institutions at all levels of basic drugs and drug bridging support policy projects; Research on the Integrated Development of Disease Prevention and Control and Medical Services in the XPCC under the Background of Healthy China (Grant No. BTJKJ2024003).

摘要:

本研究旨在评估湖北省血糖仪和血糖试纸的价格及其构成, 以提高糖尿病患者血糖监测的可负担性。采用世界卫生组织(World Health Organization, WHO)和国际健康行动机构(Health Action International, HAI)共同制定的评估药物价格构成分析法, 通过文献回顾、政策梳理和关键知情人访谈收集中央层面数据, 并在武汉市和宜昌市进行实地调研追溯供应链各层面价格数据。中央层面数据显示, 我国目前已出台多项血糖仪及血糖试纸管理和影响价格组成的相关政策, 但尚未出台对于血糖仪和血糖试纸的价格限制政策; 供应链层面数据显示, 湖北省血糖仪和试纸的价格构成主要由制造商价格和零售商加价组成, 其次是供应链税费和批发商加价。由此可知, 我国已经通过一系列政策建立了一套全面的医疗器械注册、销售、质量控制和管理规范体系, 目前我国尚未出台对于血糖仪和血糖试纸的价格政策, 因此可以通过纳入医保、政府补贴、竞争性招标、降低供应链税费降低产品价格, 进而提升糖尿病患者血糖监测可负担性。

关键词: WHO/HAI标准调查法, 湖北省, 血糖仪, 血糖试纸, 价格组成

Abstract:

The purpose of this study is to evaluate the price and composition of blood glucose meters and blood glucose test papers in Hubei Province, so as to improve the affordability of blood glucose monitoring for diabetes patients. Using the standard survey method jointly developed by the World Health Organization (WHO) and Health Action International (HAI) for drug price composition analysis, central level data was collected through literature review, policy review, and interviews with key informants. Field research was conducted in Wuhan and Yichang to trace price data at various levels of the supply chain. At the central level, data shows that China has implemented multiple policies related to the management and pricing of blood glucose meters and test strips, but has not yet introduced price restrictions for blood glucose meters and test strips; At the supply chain level, data shows that the price composition of blood glucose meters and test strips in Hubei Province is mainly composed of manufacturer prices and retail markups, followed by supply chain taxes and wholesale markups. It can be seen from this that China has established a comprehensive medical device registration, sales, quality control and management standard system through a series of policies. At present, China has not issued price policies for blood glucose meters and blood glucose test papers. Therefore, we can reduce product prices by including medical insurance, government subsidies, competitive bidding, and reducing supply chain taxes, thus improving the affordability of blood glucose monitoring for diabetes patients.

Key words: WHO/HAI standard survey method, Hubei province, Blood glucose meters, Blood glucose test strips, Price composition

Supporting: